CHAIN Biotechnology
Marlow
About CHAIN Biotechnology
CHAIN Biotechnology is a microbiome therapeutics company with a novel drug development platform targeting chronic gut-related diseases. CHAIN is developing several therapeutic compounds targeted to the gut microbiome in the large intestine that can be delivered by our CADD technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $3.0M
- Funding stage: Seed
- Last round: Seed (Jul 2023)
- Website: chainbiotech.com
- Phone: +44011584673
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/chain-biotechnology-24618 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.